- $288.68bn
- $313.21bn
- $54.07bn
- 86
- 33
- 78
- 73
REG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - AstraZeneca prices a $5bn bond offering
AnnouncementREG - AstraZeneca PLC - Filing of Form 20-F with SEC
AnnouncementREG - AstraZeneca PLC - Annual Financial Report
AnnouncementREG - AstraZeneca PLC - AstraZeneca completes acquisition of Icosavax
AnnouncementREG - AstraZeneca PLC - FDA accepts Dato-DXd BLA for nonsquamous NSCLC
AnnouncementREG - AstraZeneca PLC - Tagrisso plus chemo approved in US for lung cancer
AnnouncementREG - AstraZeneca PLC - Tagrisso improved PFS in Stage III lung cancer
AnnouncementREG - AstraZeneca PLC - Final Results
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - AstraZeneca acquires Gracell
AnnouncementREG - AstraZeneca PLC - Wainua (eplontersen) granted first US FDA approval
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
AnnouncementREG - AstraZeneca PLC - AstraZeneca to acquire Icosavax
AnnouncementREG - AstraZeneca PLC - Block listing Interim Review
AnnouncementREG - AstraZeneca PLC - Total Voting Rights
AnnouncementREG - AstraZeneca PLC - Discontinuation of two CRYSTALIZE evidence trials
AnnouncementREG - AstraZeneca PLC - Director/PDMR Shareholding
Announcement